Cargando…
The Lantibiotic Lacticin 3147 Prevents Systemic Spread of Staphylococcus aureus in a Murine Infection Model
The objective of this study was to investigate the in vivo activity of the lantibiotic lacticin 3147 against the luminescent Staphylococcus aureus strain Xen 29 using a murine model. Female BALB/c mice (7 weeks old, 17 g) were divided into groups (n = 5) and infected with the Xen 29 strain via the i...
Autores principales: | Piper, Clare, Casey, Pat G., Hill, Colin, Cotter, Paul D., Ross, R. Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265090/ https://www.ncbi.nlm.nih.gov/pubmed/22291709 http://dx.doi.org/10.1155/2012/806230 |
Ejemplares similares
-
Manipulation of charged residues within the two‐peptide lantibiotic lacticin 3147
por: Deegan, Lucy H., et al.
Publicado: (2010) -
The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria
por: Draper, Lorraine A, et al.
Publicado: (2013) -
Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity
por: O'Connor, Eileen B, et al.
Publicado: (2007) -
Saturation mutagenesis of selected residues of the α-peptide of the lantibiotic lacticin 3147 yields a derivative with enhanced antimicrobial activity
por: Field, Des, et al.
Publicado: (2013) -
Pharmaceutical design of a delivery system for the bacteriocin lacticin 3147
por: Ryan, Aoibhín, et al.
Publicado: (2021)